Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Most Excellent results!

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston May 10, 2023 1:44pm

209 Views

Post# 35441204

RE:RE:RE:RE:Most Excellent results!

Riverrow ... Fair to assume that, on top of upfront payment, TLT could negotiate a royalty of, let's assume, 10%.

So for a 100,000$US treatment, your 10,000$ revenue sounds legitimate.

So 5000 treatments (10% of the market to start with) X 10,000$US = 50MM$US revenues X p/e of 20 = 1B$US valuation.

But let's get Breakthrough designation first, and hopefully Accelerated Approval as it's this latest that could allow us to get revenues much earlier than in 2026.

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs